Crypto firm Ripple recently announced its mission to be the one-stop shop for crypto infrastructure. This came as the firm highlighted the acquisitions it made this year in a bid to achieve this mission.  Ripple Unveils One-Stop Shop For Digital Asset Infrastructure  In a blog post, Ripple touted itself as the one-stop for crypto infrastructure. […]Crypto firm Ripple recently announced its mission to be the one-stop shop for crypto infrastructure. This came as the firm highlighted the acquisitions it made this year in a bid to achieve this mission.  Ripple Unveils One-Stop Shop For Digital Asset Infrastructure  In a blog post, Ripple touted itself as the one-stop for crypto infrastructure. […]

Ripple Announces Groundbreaking “One-Stop Shop” For Everything, Here’s What It Is

2025/12/07 00:30
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Crypto firm Ripple recently announced its mission to be the one-stop shop for crypto infrastructure. This came as the firm highlighted the acquisitions it made this year in a bid to achieve this mission. 

Ripple Unveils One-Stop Shop For Digital Asset Infrastructure 

In a blog post, Ripple touted itself as the one-stop for crypto infrastructure. The firm noted that it had invested almost $4 billion into the crypto ecosystem through strategic investments and acquisitions. It added that 2025 marked its most ambitious year yet with four major acquisitions pointing toward one mission of being the one-stop infrastructure provider for moving value the way information moves today. 

Ripple stated that some acquisitions will plug directly into Ripple payments to give its customers a unified, seamless operating environment with even more capabilities and currencies. Meanwhile, others will operate independently while benefiting from shared infrastructure. The firm noted that together, these companies will bring it closer to owning the full financial plumbing behind global value movement. 

Furthermore, the company noted that businesses are operating in real time, but their financial infrastructure still isn’t. The firm believes that its unified offering gives companies the ability to bring their money management and movement up to the expectations of the digital world. It then went on to highlight how its newest acquisitions are critical to powering this change. 

Highlighting The Role Of Its Latest Acquisitions 

The firm stated that its now-closed acquisition of GTreasury marks a significant expansion into the multi-trillion-dollar corporate finance arena, a market that it noted many predict will lead the next phase of crypto adoption. The firm further remarked that through access to the global repo market via Ripple Prime and Ripple Payments’ real-time cross-border rails, corporate treasury teams can unlock idle capital, move money instantly, and open up new growth opportunities. 

Ripple then highlighted its $200 million acquisition of Rail, which it stated will make the firm’s Payments the market’s most comprehensive end-to-end stablecoin payments solution. The firm said that it is compliantly connecting the best of fiat and crypto assets so that businesses can move money faster, save costs, and build to grow. 

Ripple stated that its acquisition of Palisade broadens the range of customer use cases for custody, which is one of its central product strategies. It noted that Palisade’s “wallet-as-a-service” technology extends the company’s Custody’s inherent appeal to banks and financial institutions that carry out high-frequency transactions. 

Lastly, the payment firm highlighted its acquisition of Hidden Road, which is now Ripple Prime. It stated that this completes the liquidity and execution layer of its one-stop shop vision. The Prime offers institutional-grade prime brokerage, clearing, and financing. This enables clients to execute OTC spot trades for major crypto assets, including XRP and RLUSD. While Palisade custodies assets and Rail moves them, Ripple noted that its brokerage business ensures that they can be traded efficiently, financed responsibly, and accessed through regulated channels.

Ripple
Market Opportunity
LETSTOP Logo
LETSTOP Price(STOP)
$0.01455
$0.01455$0.01455
-1.88%
USD
LETSTOP (STOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09